News|Articles|July 23, 2013
Focusing on Quality for Parenteral Drug Manufacturing
Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.
Advertisement
Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
2
Renewing Prosaic Generics for Cancer Treatment
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
5